Perigon Wealth Management’s Chemours CC Stock Holding History

Perigon Wealth Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-470	Closed	-$23K	–	294
2018 Q1	$23K	Hold	470	–	–	0.01%	414
2017 Q4	$24K	Hold	470	–	–	0.01%	381
2017 Q3	$24K	Hold	470	–	–	0.01%	426
2017 Q2	$18K	Hold	470	–	–	﹤0.01%	454
2017 Q1	$18K	Hold	470	–	–	﹤0.01%	475
2016 Q4	$16K	Hold	470	–	–	﹤0.01%	496
2016 Q3	$8K	Hold	470	–	–	﹤0.01%	501
2016 Q2	$4K	Buy	+470	New	+$4.19K	﹤0.01%	400

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Perigon Wealth Management's CC Position: Q2 2018 in Review

Perigon Wealth Management sold out of Chemours (CC) in Q2 2018, closing a stake of 470 shares — an estimated $23K sold.

Perigon Wealth Management first reported a position in CC in Q2 2016 and held it in 8 quarters. The position peaked at $24K in Q4 2017. 558 funds tracked by Wall St. Rank hold CC as of Q2 2018.

Perigon Wealth Management reported no remaining Chemours position as of Q2 2018 after selling out during the quarter.
Perigon Wealth Management sold 470 Chemours shares in Q2 2018, an estimated $23K.
Perigon Wealth Management first reported a position in Chemours in Q2 2016 and held it in 8 quarters.
Perigon Wealth Management's Chemours position peaked at $24K in Q4 2017.
558 funds tracked by Wall St. Rank held Chemours as of Q2 2018.

Based on Perigon Wealth Management's 13F filing for Q2 2018, filed 7 Aug 2018.